MCID: LRN003
MIFTS: 49

Learning Disability

Categories: Mental diseases, Neuronal diseases

Aliases & Classifications for Learning Disability

MalaCards integrated aliases for Learning Disability:

Name: Learning Disability 12 15
Learning Disabilities 53 29 6 42 43 15 71
Learning Disorders 54 71
Academic Skill Disorder 12
Learning Disorder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8927
MeSH 43 D007859
NCIt 49 C89334
SNOMED-CT 67 1855002
ICD10 32 F81.9
UMLS 71 C0023186 C0751265

Summaries for Learning Disability

MedlinePlus : 42 What is a learning disability? Learning disabilities are conditions that affect the ability to learn. They can cause problems with Understanding what people are saying Speaking Reading Writing Doing math Paying attention Often, children have more than one kind of learning disability. They may also have another condition, such as attention deficit hyperactivity disorder (ADHD), which can make learning even more of a challenge. What causes learning disabilities? Learning disabilities don't have anything to do with intelligence. They are caused by differences in the brain, and they affect the way the brain processes information. These differences are usually present at birth. But there are certain factors that can play a role in the development of a learning disability, including Genetics Environmental exposures (such as lead) Problems during pregnancy (such as the mother's drug use) How do I know if my child has a learning disability? The earlier you can find and treat a learning disability, the better. Unfortunately, learning disabilities are usually not recognized until a child is in school. If you notice that your child is struggling, talk to your child's teacher or health care provider about an evaluation for a learning disability. The evaluation may include a medical exam, a discussion of family history, and intellectual and school performance testing. What are the treatments for learning disabilities? The most common treatment for learning disabilities is special education. A teacher or other learning specialist can help your child learn skills by building on strengths and finding ways to make up for weaknesses. Educators may try special teaching methods, make changes to the classroom, or use technologies that can assist your child's learning needs. Some children also get help from tutors or speech or language therapists. A child with a learning disability may struggle with low self-esteem, frustration, and other problems. Mental health professionals can help your child understand these feelings, develop coping tools, and build healthy relationships. If your child has another condition such as ADHD, he or she will need treatment for that condition as well. NIH: National Institute of Child Health and Human Development

MalaCards based summary : Learning Disability, also known as learning disabilities, is related to specific learning disability and sotos syndrome 1. An important gene associated with Learning Disability is FIBP (FGF1 Intracellular Binding Protein), and among its related pathways/superpathways are Neuroscience and MAP Kinase Signaling. The drugs Aripiprazole and Sodium citrate have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and eye, and related phenotypes are behavior/neurological and growth/size/body region

Disease Ontology : 12 A specific developmental disorder that involves difficulty in scholastic skills such as reading, writing, spelling, reasoning, recalling and/or organizing information resulting from the brain's inability to receive and process information.

NINDS : 53 Learning disabilities are disorders that affect the ability to understand or use spoken or written language, do mathematical calculations, coordinate movements, or direct attention. Although learning disabilities occur in very young children, the disorders are usually not recognized until the child reaches school age. Research shows that 8 to 10 percent of American children under 18 years of age have some type of learning disability.

Wikipedia : 74 Learning disability, learning disorder or learning difficulty (British English) is a condition in the... more...

Related Diseases for Learning Disability

Diseases related to Learning Disability via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 460, show less)
# Related Disease Score Top Affiliating Genes
1 specific learning disability 34.3 SYNE2 RPS6KA3 PTPN11 NF1 IQSEC2 CACNA1A
2 sotos syndrome 1 33.7 NF1 MECP2 FMR1
3 dyscalculia 32.3 PRODH CFAP47
4 legius syndrome 32.1 PTPN11 NF1
5 specific developmental disorder 31.5 PRODH NF1 MECP2 MAPT FMR1 CFAP47
6 alacrima, achalasia, and mental retardation syndrome 31.1 PURA MECP2 IQSEC2 FMR1 CACNA1A
7 disease of mental health 30.9 PRODH MECP2 MAPT FMR1
8 autism spectrum disorder 30.5 PRODH NF1 MECP2 IQSEC2 FMR1 CDH8
9 autism 30.5 TBL1XR1 PRODH NF1 MECP2 MAPT IQSEC2
10 lennox-gastaut syndrome 30.4 MECP2 IQSEC2 CACNA1A
11 west syndrome 30.4 TBL1XR1 MECP2 IQSEC2 CACNA1A
12 epileptic encephalopathy, early infantile, 6 30.1 MECP2 IQSEC2 CACNA1A
13 childhood disintegrative disease 30.1 MECP2 FMR1
14 heart septal defect 30.0 PTPN11 PRODH CFAP47
15 atrial heart septal defect 29.9 PTPN11 PRODH CFAP47
16 chromosomal deletion syndrome 29.7 PRODH MECP2 FMR1
17 epilepsy, x-linked, with variable learning disabilities and behavior disorders 12.7
18 shprintzen omphalocele syndrome 12.2
19 giacheti syndrome 11.6
20 feingold syndrome 1 11.6
21 dysgraphia 11.6
22 fragile x syndrome 11.6
23 grange syndrome 11.5
24 turner syndrome 11.5
25 47,xyy 11.5
26 dyslexia 11.5
27 prader-willi syndrome 11.4
28 digeorge syndrome 11.4
29 neurofibromatosis, type i 11.4
30 silver-russell syndrome 11.4
31 velocardiofacial syndrome 11.4
32 speech and communication disorders 11.4
33 down syndrome 11.3
34 reading disorder 11.3
35 writing disorder 11.3
36 saethre-chotzen syndrome 11.3
37 neural tube defects 11.3
38 cerebellar hypoplasia 11.3
39 dandy-walker syndrome 11.3
40 histidinemia 11.3
41 thauvin-robinet-faivre syndrome 11.3
42 fetal alcohol syndrome 11.3
43 myopathy with extrapyramidal signs 11.2
44 microphthalmia, syndromic 3 11.1
45 bloom syndrome 11.1
46 robin sequence with cleft mandible and limb anomalies 11.1
47 osteopathia striata with cranial sclerosis 11.1
48 shukla-vernon syndrome 11.1
49 neuropathy, ataxia, and retinitis pigmentosa 11.1
50 pierpont syndrome 11.1
51 glut1 deficiency syndrome 1 11.1
52 perrault syndrome 3 11.1
53 leukoencephalopathy with ataxia 11.1
54 bardet-biedl syndrome 12 11.1
55 retinal dystrophy, juvenile cataracts, and short stature syndrome 11.1
56 glycosylphosphatidylinositol biosynthesis defect 17 11.1
57 48,xxyy syndrome 11.1
58 spastic paraplegia 20, autosomal recessive 11.0
59 apert syndrome 11.0
60 atelosteogenesis, type iii 11.0
61 centralopathic epilepsy 11.0
62 cherubism 11.0
63 van der woude syndrome 1 11.0
64 popliteal pterygium syndrome 11.0
65 coffin-siris syndrome 1 11.0
66 shprintzen-goldberg craniosynostosis syndrome 11.0
67 septooptic dysplasia 11.0
68 sturge-weber syndrome 11.0
69 charge syndrome 11.0
70 neuropathy, hereditary sensory and autonomic, type iii 11.0
71 carbamoyl phosphate synthetase i deficiency, hyperammonemia due to 11.0
72 n-acetylglutamate synthase deficiency 11.0
73 hyperornithinemia-hyperammonemia-homocitrullinuria syndrome 11.0
74 lipoid proteinosis of urbach and wiethe 11.0
75 3mc syndrome 3 11.0
76 mucolipidosis iii alpha/beta 11.0
77 3mc syndrome 1 11.0
78 3mc syndrome 2 11.0
79 mental retardation, x-linked, syndromic 13 11.0
80 adrenoleukodystrophy 11.0
81 hypomelanosis of ito 11.0
82 anemia, sideroblastic, and spinocerebellar ataxia 11.0
83 branchial arch syndrome, x-linked 11.0
84 hypocalciuric hypercalcemia, familial, type iii 11.0
85 van den ende-gupta syndrome 11.0
86 scheie syndrome 11.0
87 lathosterolosis 11.0
88 chromosome 22q11.2 duplication syndrome 11.0
89 2-methylbutyryl-coa dehydrogenase deficiency 11.0
90 xfe progeroid syndrome 11.0
91 pseudopseudohypoparathyroidism 11.0
92 spastic paraplegia 45, autosomal recessive 11.0
93 feingold syndrome 2 11.0
94 bone marrow failure syndrome 2 11.0
95 bardet-biedl syndrome 11 11.0
96 spinocerebellar ataxia, autosomal recessive 21 11.0
97 spasticity, childhood-onset, with hyperglycinemia 11.0
98 short stature, brachydactyly, intellectual developmental disability, and seizures 11.0
99 epilepsy, early-onset, vitamin b6-dependent 11.0
100 adams-oliver syndrome 11.0
101 chromosome 19q13.11 deletion syndrome 11.0
102 hypogonadotropic hypogonadism 11.0
103 landau-kleffner syndrome 11.0
104 prosopagnosia 11.0
105 bacterial meningitis 11.0
106 triple x syndrome 11.0
107 clcn2-related leukoencephalopathy 11.0
108 carbonic anhydrase va deficiency 11.0
109 glucose transporter type 1 deficiency syndrome 11.0
110 zellweger spectrum disorder 11.0
111 1q duplications 11.0
112 chromosome 20 trisomy 11.0
113 distal chromosome 18q deletion syndrome 11.0
114 familial glucocorticoid deficiency 11.0
115 fetal retinoid syndrome 11.0
116 ophn1 syndrome 11.0
117 ring chromosome 21 11.0
118 ring chromosome 9 11.0
119 epilepsy-aphasia spectrum 11.0
120 de morsier's syndrome information 11.0
121 mucolipidoses 11.0
122 epilepsy with bilateral occipital calcifications 10.8
123 epilepsy, pyridoxine-dependent 10.8
124 wilson-turner x-linked mental retardation syndrome 10.8
125 pyridoxamine 5-prime-phosphate oxidase deficiency 10.8
126 attention deficit-hyperactivity disorder 10.7
127 paralytic lagophthalmos 10.6 NF1 MAPT
128 skin granular cell tumor 10.6 PTPN11 NF1
129 neurofibromatosis-noonan syndrome 10.5 PTPN11 NF1
130 syndromic intellectual disability 10.5 MECP2 MAPT IQSEC2
131 thymic dysplasia 10.5 PRODH IQSEC2
132 fragile x tremor/ataxia syndrome 10.5 PURA FMR1
133 familial retinoblastoma 10.4 NF1 MYCN
134 cortical deafness 10.4 SYNE2 MAPT
135 stereotypic movement disorder 10.4 PRODH MECP2
136 echolalia 10.4 MECP2 MAPT FMR1
137 bone structure disease 10.4 PRODH NF1 MECP2
138 electroclinical syndrome 10.4 PRODH MECP2 CACNA1A
139 epilepsy 10.4
140 contractures, pterygia, and variable skeletal fusions syndrome 1a 10.4 PTPN11 PRODH NF1 CACNA1A
141 non-syndromic x-linked intellectual disability 10.4 RPS6KA3 MECP2 IQSEC2 FMR1
142 sarcoma, synovial 10.4 NF1 MYCN CFAP47
143 movement disease 10.3 MAPT FMR1 CACNA1A
144 non-syndromic intellectual disability 10.3 PRODH IQSEC2 CFAP47
145 patent ductus arteriosus 1 10.3 PTPN11 PRODH CFAP47
146 anxiety 10.3
147 neurofibromatosis, type iv, of riccardi 10.3
148 pitt-hopkins-like syndrome 1 10.3 MECP2 FMR1
149 hand skill, relative 10.3
150 pathologic nystagmus 10.3
151 chromosomal disease 10.2 PRODH MECP2 MAPT FMR1
152 atrial septal defect 9 10.2 PRODH CFAP47
153 depression 10.2
154 personality disorder 10.2
155 seizure disorder 10.2
156 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.2
157 gonadal dysgenesis 10.2
158 cerebral palsy 10.2
159 strabismus 10.2
160 asperger syndrome 10.2
161 aphasia 10.2
162 visual epilepsy 10.2
163 mechanical strabismus 10.2
164 atypical autism 10.1 MECP2 FMR1
165 schizophrenia 10.1
166 refractive error 10.1
167 x-linked monogenic disease 10.1 RPS6KA3 PRODH MECP2 FMR1 CFAP47
168 cleft palate, isolated 10.1
169 gilles de la tourette syndrome 10.1
170 obsessive-compulsive disorder 10.1
171 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 10.1
172 mental depression 10.1
173 otitis media 10.1
174 arts syndrome 10.1
175 striatal degeneration, autosomal dominant 2 10.1
176 dementia 10.1
177 microcephaly 10.1
178 developmental dyspraxia 10.1
179 alzheimer disease 10.0
180 major affective disorder 1 10.0
181 abnormal hair, joint laxity, and developmental delay 10.0
182 frontotemporal lobar degeneration with tdp43 inclusions, grn-related 10.0
183 major depressive disorder 10.0
184 hydrocephalus 10.0
185 conduct disorder 10.0
186 psychotic disorder 10.0
187 substance abuse 10.0
188 brain injury 10.0
189 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
190 apraxia 10.0
191 constipation 10.0
192 speech disorder 10.0
193 developmental coordination disorder 10.0
194 chromosomal triplication 10.0
195 pelizaeus-merzbacher-like disease 10.0
196 hypotonia 10.0
197 traumatic brain injury 10.0
198 specific language disorder 10.0
199 lipoid congenital adrenal hyperplasia 9.9
200 ataxia and polyneuropathy, adult-onset 9.9
201 major affective disorder 8 9.9
202 major affective disorder 9 9.9
203 pervasive developmental disorder 9.9
204 myelomeningocele 9.9
205 myopia 9.9
206 pica disease 9.9
207 avoidant personality disorder 9.9
208 ventricular septal defect 9.9
209 status epilepticus 9.9
210 dental caries 9.9
211 craniosynostosis 9.9
212 bipolar disorder 9.9
213 mood disorder 9.9
214 temporal lobe epilepsy 9.9
215 gerstmann syndrome 9.9
216 cataract 9.9
217 eating disorder 9.9
218 cleft lip 9.9
219 47, xxy 9.9
220 alcohol dependence 9.8
221 migraine with or without aura 1 9.8
222 tuberous sclerosis 1 9.8
223 galactosemia 9.8
224 metachromatic leukodystrophy 9.8
225 body mass index quantitative trait locus 11 9.8
226 dysphasia, familial developmental 9.8
227 body mass index quantitative trait locus 9 9.8
228 body mass index quantitative trait locus 8 9.8
229 cervical cancer 9.8
230 body mass index quantitative trait locus 4 9.8
231 body mass index quantitative trait locus 10 9.8
232 body mass index quantitative trait locus 7 9.8
233 body mass index quantitative trait locus 12 9.8
234 body mass index quantitative trait locus 14 9.8
235 microvascular complications of diabetes 5 9.8
236 body mass index quantitative trait locus 18 9.8
237 body mass index quantitative trait locus 19 9.8
238 body mass index quantitative trait locus 20 9.8
239 brachydactyly 9.8
240 alexithymia 9.8
241 pain agnosia 9.8
242 agraphia 9.8
243 stuttering 9.8
244 specific language impairment 9.8
245 ptosis 9.8
246 physical disorder 9.8
247 sensorineural hearing loss 9.8
248 esophageal atresia 9.8
249 leukodystrophy 9.8
250 borderline personality disorder 9.8
251 antisocial personality disorder 9.8
252 synostosis 9.8
253 transvestism 9.8
254 fetishism 9.8
255 hepatitis a 9.8
256 tuberous sclerosis 9.8
257 neuroleptic malignant syndrome 9.8
258 hypogonadism 9.8
259 focal epilepsy 9.8
260 tic disorder 9.8
261 ischemia 9.8
262 myopathy 9.8
263 sleep disorder 9.8
264 cerebrovascular disease 9.8
265 hypogonadotropism 9.8
266 delusional disorder 9.8
267 48,xyyy 9.8
268 allergic encephalomyelitis 9.8
269 dysphagia 9.8
270 head injury 9.8
271 headache 9.8
272 cleft lip/palate 9.8
273 posterior cortical atrophy 9.8
274 achondroplasia 9.7
275 autoimmune disease 9.7
276 coloboma of macula 9.7
277 cri-du-chat syndrome 9.7
278 discrimination, two-point, reduction in 9.7
279 fibromuscular dysplasia 9.7
280 hair whorl 9.7
281 systemic lupus erythematosus 9.7
282 medulloblastoma 9.7
283 palatopharyngeal incompetence 9.7
284 chromosome 2q35 duplication syndrome 9.7
285 triiodothyronine receptor auxiliary protein 9.7
286 varicose veins 9.7
287 williams-beuren syndrome 9.7
288 central hypoventilation syndrome, congenital 9.7
289 chondrodysplasia punctata syndrome 9.7
290 citrullinemia, classic 9.7
291 duodenal atresia 9.7
292 hartnup disorder 9.7
293 hydrocephalus, normal-pressure 9.7
294 hyperlexia 9.7
295 miller-dieker lissencephaly syndrome 9.7
296 maple syrup urine disease 9.7
297 myasthenia gravis 9.7
298 3-methylglutaconic aciduria, type iii 9.7
299 phenylketonuria 9.7
300 taurodontism 9.7
301 lubs x-linked mental retardation syndrome 9.7
302 hsd10 mitochondrial disease 9.7
303 autism x-linked 2 9.7
304 incontinentia pigmenti 9.7
305 muscular dystrophy, duchenne type 9.7
306 premature ovarian failure 1 9.7
307 rett syndrome 9.7
308 dyslexia 2 9.7
309 frontotemporal dementia 9.7
310 cleft palate, cardiac defects, and mental retardation 9.7
311 stroke, ischemic 9.7
312 yemenite deaf-blind hypopigmentation syndrome 9.7
313 branchiootic syndrome 1 9.7
314 brittle bone disorder 9.7
315 sickle cell anemia 9.7
316 late-onset retinal degeneration 9.7
317 propionic acidemia 9.7
318 anorexia nervosa 9.7
319 pulmonary disease, chronic obstructive 9.7
320 allergic rhinitis 9.7
321 coronary heart disease 1 9.7
322 bulimia nervosa 9.7
323 koolen-de vries syndrome 9.7
324 glass syndrome 9.7
325 chromosome 17q11.2 deletion syndrome, 1.4-mb 9.7
326 tumor predisposition syndrome 9.7
327 tyshchenko syndrome 9.7
328 mental retardation, autosomal dominant 31 9.7
329 craniosynostosis 6 9.7
330 chromosome 15q14 deletion syndrome 9.7
331 chorea, childhood-onset, with psychomotor retardation 9.7
332 gabriele-de vries syndrome 9.7
333 helix syndrome 9.7
334 developmental delay with or without dysmorphic facies and autism 9.7
335 chronic ulcer of skin 9.7
336 lissencephaly 9.7
337 periventricular nodular heterotopia 9.7
338 exanthem 9.7
339 arterial calcification of infancy 9.7
340 alcohol-related birth defect 9.7
341 metabolic acidosis 9.7
342 oppositional defiant disorder 9.7
343 finger agnosia 9.7
344 basal ganglia calcification 9.7
345 omphalocele 9.7
346 pollen allergy 9.7
347 syndromic x-linked intellectual disability type 10 9.7
348 myoglobinuria 9.7
349 migraine with aura 9.7
350 exhibitionism 9.7
351 thalassemia 9.7
352 mumps 9.7
353 osteomalacia 9.7
354 amnestic disorder 9.7
355 hemiplegia 9.7
356 depersonalization disorder 9.7
357 hypoparathyroidism 9.7
358 social phobia 9.7
359 presbyopia 9.7
360 protein-energy malnutrition 9.7
361 spinal muscular atrophy 9.7
362 leukemia 9.7
363 acute leukemia 9.7
364 pyloric stenosis 9.7
365 migraine without aura 9.7
366 choreatic disease 9.7
367 periventricular leukomalacia 9.7
368 gout 9.7
369 porphyria 9.7
370 reye syndrome 9.7
371 hypothyroidism 9.7
372 methylmalonic acidemia 9.7
373 alcohol use disorder 9.7
374 conversion disorder 9.7
375 vascular disease 9.7
376 calcinosis 9.7
377 impotence 9.7
378 post-traumatic stress disorder 9.7
379 testicular cancer 9.7
380 food allergy 9.7
381 demyelinating disease 9.7
382 central nervous system disease 9.7
383 histrionic personality disorder 9.7
384 mastocytosis 9.7
385 congenital myasthenic syndrome 9.7
386 skin disease 9.7
387 agnosia 9.7
388 neuromuscular disease 9.7
389 nominal aphasia 9.7
390 neurotic disorder 9.7
391 adjustment disorder 9.7
392 middle ear disease 9.7
393 infertility 9.7
394 dystonia 9.7
395 kidney disease 9.7
396 peripheral nervous system disease 9.7
397 panic disorder 9.7
398 acute stress disorder 9.7
399 muscular atrophy 9.7
400 chronic kidney disease 9.7
401 scabies 9.7
402 intestinal obstruction 9.7
403 measles 9.7
404 nervous system disease 9.7
405 neuropathy 9.7
406 rubella 9.7
407 lupus erythematosus 9.7
408 tyrosinemia 9.7
409 postpartum depression 9.7
410 encephalitis 9.7
411 muscular dystrophy 9.7
412 myotonic dystrophy 9.7
413 charcot-marie-tooth hereditary neuropathy 9.7
414 isolated methylmalonic acidemia 9.7
415 satb2-associated syndrome 9.7
416 shox deficiency disorders 9.7
417 aminoaciduria 9.7
418 carcinoma showing thymus-like differentiation 9.7
419 chromosome 9q duplication 9.7
420 cluttering 9.7
421 congenital hydrocephalus 9.7
422 dentinogenesis imperfecta type 2 9.7
423 fibromatosis 9.7
424 growth hormone deficiency 9.7
425 haemophilus influenzae 9.7
426 logopenic progressive aphasia 9.7
427 madelung deformity 9.7
428 pituitary stalk interruption syndrome 9.7
429 pseudobulbar affect 9.7
430 retinochoroidal coloboma 9.7
431 age-related hearing loss 9.7
432 febrile seizures 9.7
433 hypersomnia 9.7
434 hypoxia 9.7
435 spasticity 9.7
436 swallowing disorders 9.7
437 tremor 9.7
438 orofacial clefting syndrome 9.7
439 complex chromosomal rearrangement 9.7
440 partial trisomy of the long arm of chromosome 9 9.7
441 syndromic obesity 9.7
442 severe early-childhood-onset retinal dystrophy 9.7
443 overgrowth syndrome 9.7
444 coronary ostial stenosis or atresia 9.7
445 arachnoid cysts, intracranial 9.5
446 epilepsy, focal, with speech disorder and with or without mental retardation 9.5
447 trichothiodystrophy 1, photosensitive 9.5
448 phobia, specific 9.5
449 fetal alcohol spectrum disorder 9.5
450 familial hemiplegic migraine 9.5
451 common cold 9.5
452 iron metabolism disease 9.5
453 neonatal jaundice 9.5
454 benign epilepsy with centrotemporal spikes 9.5
455 mutism 9.5
456 elective mutism 9.5
457 hemiplegic migraine 9.5
458 aneurysm 9.5
459 rapidly involuting congenital hemangioma 9.5
460 mycoplasma encephalitis 9.5

Graphical network of the top 20 diseases related to Learning Disability:



Diseases related to Learning Disability

Symptoms & Phenotypes for Learning Disability

MGI Mouse Phenotypes related to Learning Disability:

45 (showing 9, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.3 BBIP1 CACNA1A CDH8 CLPP FMR1 MAPT
2 growth/size/body region MP:0005378 10.28 BBIP1 CACNA1A CLPP FMR1 MAPT MECP2
3 homeostasis/metabolism MP:0005376 10.22 CACNA1A CLPP COLEC11 MAPT MECP2 MYCN
4 integument MP:0010771 10.15 CACNA1A CDH8 CLPP FMR1 MAPT MECP2
5 nervous system MP:0003631 10.1 BBIP1 CACNA1A CDH8 FMR1 MAPT MECP2
6 muscle MP:0005369 9.87 CACNA1A MAPT MYCN NF1 PTPN11 RPS6KA3
7 reproductive system MP:0005389 9.81 BBIP1 CACNA1A CLPP FMR1 MECP2 MYCN
8 respiratory system MP:0005388 9.61 CACNA1A MECP2 MYCN NF1 NPAS3 PTPN11
9 vision/eye MP:0005391 9.36 BBIP1 CACNA1A CDH8 FMR1 MAPT MECP2

Drugs & Therapeutics for Learning Disability

Drugs for Learning Disability (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 162, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
2
Sodium citrate Approved, Investigational Phase 4 68-04-2
3
Caffeine Approved Phase 4 58-08-2 2519
4
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
5
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
6
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
7
Methyltestosterone Approved Phase 4 58-18-4 6010
8
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
9
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 6013 10204
10
Testosterone enanthate Approved Phase 4 315-37-7 9416
11
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
12
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
13
Amphetamine Approved, Illicit, Investigational Phase 4 300-62-9 5826 3007
14
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
15
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
16
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
17
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
18 Antipsychotic Agents Phase 4
19 Tranquilizing Agents Phase 4
20 Serotonin Agents Phase 4
21 Psychotropic Drugs Phase 4
22 Dopamine Antagonists Phase 4
23 Serotonin Antagonists Phase 4
24 Serotonin Receptor Agonists Phase 4
25 Serotonin 5-HT1 Receptor Agonists Phase 4
26 Dopamine agonists Phase 4
27 Antidepressive Agents Phase 4
28 Dopamine D2 Receptor Antagonists Phase 4
29 Serotonin 5-HT2 Receptor Antagonists Phase 4
30 Calcium, Dietary Phase 4
31 Anticoagulants Phase 4
32 Chelating Agents Phase 4
33 Citrate Phase 4
34 Caffeine citrate Phase 4
35 Phosphodiesterase Inhibitors Phase 4
36 Trace Elements Phase 4
37 Vitamins Phase 4
38 Vitamin B Complex Phase 4
39 Micronutrients Phase 4
40 Respiratory System Agents Phase 4
41 Nutrients Phase 4
42 Protective Agents Phase 4
43 Free Radical Scavengers Phase 4
44 Folate Phase 4
45 N-monoacetylcystine Phase 4
46 Omega 3 Fatty Acid Phase 4
47 Antidotes Phase 4
48 Vitamin B9 Phase 4
49 Expectorants Phase 4
50 Anti-Infective Agents Phase 4
51 Antioxidants Phase 4
52 Antiviral Agents Phase 4
53 Dopamine Agents Phase 4
54 Central Nervous System Stimulants Phase 4
55 Dopamine Uptake Inhibitors Phase 4
56 Anti-Bacterial Agents Phase 4
57 Autonomic Agents Phase 4
58 Antibiotics, Antitubercular Phase 4
59 Hormones Phase 4
60 Anabolic Agents Phase 4
61 Antineoplastic Agents, Hormonal Phase 4
62 Hormone Antagonists Phase 4
63 Testosterone 17 beta-cypionate Phase 4
64 Androgens Phase 4
65 Amoxicillin-Potassium Clavulanate Combination Phase 4
66 beta-Lactamase Inhibitors Phase 4
67 Sympathomimetics Phase 4
68 Neurotransmitter Agents Phase 4
69 Adrenergic Agonists Phase 4
70 Adrenergic alpha-2 Receptor Agonists Phase 4
71 Adrenergic Agents Phase 4
72 Antihypertensive Agents Phase 4
73
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
74
Sirolimus Approved, Investigational Phase 2, Phase 3 53123-88-9 5284616 6436030 46835353
75
Everolimus Approved Phase 2, Phase 3 159351-69-6 6442177 70789204
76
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3 22916-47-8 4189
77
Risperidone Approved, Investigational Phase 3 106266-06-2 5073
78
Memantine Approved, Investigational Phase 3 19982-08-2 4054
79
Sevoflurane Approved, Vet_approved Phase 3 28523-86-6 5206
80
Dexmedetomidine Approved, Vet_approved Phase 3 113775-47-6 5311068 68602
81
Remifentanil Approved Phase 3 132875-61-7 60815
82
Isoflurane Approved, Vet_approved Phase 3 26675-46-7 3763
83 Antifungal Agents Phase 2, Phase 3
84 Immunosuppressive Agents Phase 2, Phase 3
85 Excitatory Amino Acid Antagonists Phase 3
86 Excitatory Amino Acids Phase 3
87 Antiparkinson Agents Phase 3
88 Platelet Aggregation Inhibitors Phase 3
89 Hematinics Phase 3
90 Epoetin alfa Phase 3 113427-24-0
91 Central Nervous System Depressants Phase 3
92 Anesthetics Phase 3
93 Analgesics, Non-Narcotic Phase 3
94 Anesthetics, Inhalation Phase 3
95 Hypnotics and Sedatives Phase 3
96 Analgesics Phase 3
97 Anesthetics, General Phase 3
98 Strawberry Approved Phase 2
99
Guaifenesin Approved, Investigational, Vet_approved Phase 2 93-14-1 3516
100
Dextromethorphan Approved Phase 2 125-71-3 5360696 5362449
101
Simvastatin Approved Phase 2 79902-63-9 54454
102
Lovastatin Approved, Investigational Phase 2 75330-75-5 53232
103
Glutamic acid Approved, Nutraceutical Phase 2 56-86-0 33032
104 Chlorpheniramine, phenylpropanolamine drug combination Phase 2
105 Antitussive Agents Phase 2
106 Hypolipidemic Agents Phase 2
107 Anticholesteremic Agents Phase 2
108 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 2
109 L 647318 Phase 2
110 Dihydromevinolin Phase 2
111 Antimetabolites Phase 2
112 Lipid Regulating Agents Phase 2
113 Nootropic Agents Phase 2
114 Phosphodiesterase 4 Inhibitors Phase 2
115
Topiramate Approved 97240-79-4 5284627
116
Lidocaine Approved, Vet_approved 137-58-6 3676
117
Minocycline Approved, Investigational 10118-90-8 5281021
118
Hexetidine Approved, Investigational 141-94-6
119
Sulfamethazine Approved, Investigational, Vet_approved 57-68-1 5327
120
Glycerol Approved, Investigational 56-81-5 753
121
Oxytocin Approved, Vet_approved 50-56-6 53477758 439302
122
carbamide peroxide Approved 124-43-6
123
Nitric Oxide Approved 10102-43-9 145068
124
Adenosine Approved, Investigational 58-61-7 60961
125 Dill Approved
126
tannic acid Approved 1401-55-4
127
Benzocaine Approved, Investigational 94-09-7, 1994-09-7 2337
128
Aspartic acid Approved, Nutraceutical 56-84-8 5960
129
Vitamin D Approved, Nutraceutical, Vet_approved 1406-16-2
130
arachidonic acid Experimental 506-32-1 444899
131 N-Methylaspartate
132 Anticonvulsants
133 Hypoglycemic Agents
134 Anesthetics, Local
135 Anti-Arrhythmia Agents
136 Sodium Channel Blockers
137 Diuretics, Potassium Sparing
138 Anti-Inflammatory Agents
139 Calciferol
140
Bilirubin 69853-43-6, 635-65-4 21252250 5280352
141 Fluorodeoxyglucose F18
142 Radiopharmaceuticals
143 Chlorhexidine gluconate
144 Dermatologic Agents
145 Antitubercular Agents
146 Disinfectants
147 Anti-Infective Agents, Local
148 Soy Bean
149 Olive
150 Lecithin
151 Complement System Proteins
152 Oxytocics
153 Anti-Asthmatic Agents
154 Vasodilator Agents
155 Bronchodilator Agents
156 Immunologic Factors
157 8-chloro-cyclic adenosine monophosphate
158 Anti-Retroviral Agents
159 Pharmaceutical Solutions
160 Tin Fluorides
161 Insulin, Globin Zinc
162 insulin

Interventional clinical trials:

(showing 176, show less)
# Name Status NCT ID Phase Drugs
1 Methylphenidate in Healthy Young Adults Unknown status NCT00815841 Phase 4 METHYLPHENIDATE
2 Aripiprazole Treatment for Antipsychotic Induced Hyperprolactinaemia in Patients With Severe Mental Illness and Learning Disabilities Completed NCT01085383 Phase 4 Aripiprazole
3 Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study Completed NCT00809055 Phase 4 Caffeine citrate
4 Language-based Learning Skills and ADHD: Impact of Treatment With Sustained-release Guanfacine Completed NCT01146002 Phase 4 Guanfacine (sustained release)
5 An Open-Label Clinical Trial Conducted Via Telepsychiatry of Complementary and Alternative Treatments (Omega-3 Fatty Acids and Inositol vs. N-acetylcysteine) for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD) Recruiting NCT03757585 Phase 4 Open-label Treatment with Omega-3 Fatty Acids + Inositol;Open-label Treatment with N-acetylcysteine
6 TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY Recruiting NCT03325647 Phase 4 Testosterone Cypionate 200 Milligram/Milliliter Injectable Solution;Placebo injectable saline
7 An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Recruiting NCT02783404 Phase 4 Amoxicillin;Amoxicillin-Potassium Clavulanate
8 Adaptive Response to Intervention (RTI) for Students With ADHD Recruiting NCT03511976 Phase 4 Stimulant
9 Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome Not yet recruiting NCT04066088 Phase 4 Guanfacine extended release (GXR)
10 Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities Unknown status NCT00246792 Phase 2, Phase 3
11 Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex Unknown status NCT01730209 Phase 2, Phase 3 Everolimus;Placebo
12 Prospective Trial of Risperdal (Risperidone) Following Psychological Therapy for Challenging Behaviour in Learning Disabled Children Completed NCT00254930 Phase 3 risperidone
13 Multicenter Double-blind Placebo-Controlled Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children Completed NCT03159104 Phase 3 Tenoten for children;Placebo
14 Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study Completed NCT00785135 Phase 3
15 Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest Completed NCT00000470 Phase 3
16 Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions: A Randomized-controlled Trial Recruiting NCT03553875 Phase 3 Memantine Hydrochloride;Placebo
17 Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery on Peri-operative Outcomes and Neurocognitive Development in Infants: A Randomized Controlled Trial Recruiting NCT02559102 Phase 3 Dexmedetomidine sedation;General sevoflurane anaesthesia
18 Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants - a Randomized, Double-blind, Placebo-controlled, Prospective, and Multicenter Clinical Study Active, not recruiting NCT02076373 Phase 3 recombinant human Erythropoietin;Placebo
19 Isoflurane-induced Neuroinflammation in Children With Hydrocephalus: A Bench-to-bedside, Translational Study of Molecular Pathways and Therapeutic Approaches Terminated NCT02512809 Phase 3 Isoflurane;Dexmedetomidine
20 Effects of Frequency Modulation (FM) Assistive Listening Device Systems on Listening and Related Skills in Children With Auditory Processing Disorders (APD) Unknown status NCT02353091 Phase 2
21 Preterm Fetal Growth Restriction and Developmental Care Unknown status NCT00166660 Phase 2
22 Erythropoetin Neuroprotection for Neonatal Cardiac Surgery Unknown status NCT00513240 Phase 1, Phase 2 Erythropoetin;Normal saline
23 Building Complex Language: Effect of Treatment and Dosage Completed NCT01337232 Phase 1, Phase 2
24 A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation Study of NNZ-2566 in Rett Syndrome Completed NCT01703533 Phase 2 NNZ-2566;Placebo
25 A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome Completed NCT02715115 Phase 2 NNZ-2566;Placebo
26 Placebo Controlled Trial of Dextromethorphan in Rett Syndrome Completed NCT01520363 Phase 2 dextromethorphan;placebo
27 Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome Completed NCT00064792 Phase 2 Simvastatin Susp.;OraPlus
28 Neurobiology and Treatment of Reading Disability in NF1 Recruiting NCT02964884 Phase 2 Lovastatin;Placebo Oral Tablet
29 A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome Recruiting NCT03569631 Phase 2 BPN14770;Placebo
30 Working Memory Training in Attention-Deficit/Hyperactivity Disorder: Neural Mechanisms of Change Unknown status NCT01657721 Phase 1
31 Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) Completed NCT00352599 Phase 1 Lovastatin;Lovastatin;placebo pill
32 VidRT: Video Distraction During Radiation Therapy to Decrease Use of Pediatric Sedation Recruiting NCT03677531 Phase 1
33 Investigation of Lycra Splinting Garments for Falls and Intellectual Disabilities Unknown status NCT02345512
34 The Contribution of Risk and Resilience Factors in Learning Disabilities Population to Academic and Emotional Development Unknown status NCT01652651
35 Efficacy and Safety of Memantine Hydrochloride, a Low Affinity Antagonist to N-Methyl-D-Aspartate (NMDA) Type Receptors, in the Prevention of Cognitive Decline and Disease Progression in Down’s Syndrome Unknown status NCT00240760 Memantine Hydrochloride
36 The Additive Effect of Cognitive Behavioral Treatment - CBT to Conventional Weight Loss Intervention Program for Young Adults With Intellectual Disabilities Unknown status NCT01032369
37 Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study Unknown status NCT00956696 topiramate
38 Teacher Help: Novel Technologies for Meeting the Immediate Needs of Youth With Mental Health Disorders in Canada Unknown status NCT02919215
39 Working Memory Training in College Students With ADHD/LD Unknown status NCT01154686
40 Study of the Neurofibromatosis 1 Expression: Identification of the Modifying Genes Unknown status NCT01650142
41 Investigating the Effects of an Added Parent Component to Cognitive Behavior Therapy for Youth With Anxiety Disorders Unknown status NCT02160444
42 Epidemiological Study for Psychiatric Disorder Among Children and Adolescents Unknown status NCT02707848
43 Development of a New Diagnosis and Intervention Method for Developmental Disorders Unknown status NCT01166152
44 Identification and Comprehension of Focused Stress in a Sentence Among Adults Who Suffered Traumatic Brain Injury Unknown status NCT02499133
45 Efficacy of External Cold and a Vibrating Device in Reducing Discomfort of Dental Injections in Children - A Split Mouth Randomized Clinical Trial Unknown status NCT02675387 2%Lidocaine
46 Dialectical Behavioral Therapy (DBT) Based Skills Group for Children With Emotional Dysregulation and Their Parents Unknown status NCT01299740
47 Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series Unknown status NCT02666495
48 A Pilot Randomized Controlled Trial to Test Effectiveness of the ACE4 (Activity Challenge - 4 Areas) for Depression and Anxiety: A Behavioural Activation Based Game. Unknown status NCT02538549
49 Randomized Control Trial of RESOLVE (Relaxation Exercise, SOLving Problem and cognitiVe Errors): A Waiting Room Intervention for Crisis Clients Unknown status NCT02536924
50 Asthma Disparities in Latino Children:Acculturation,Illness Representations & CAM Unknown status NCT01099800
51 Is a Primer Needed for Orthodontic Bonding? A Multi-centre RCT Unknown status NCT01782521
52 Using New Genetic Technology to Diagnose Neurodevelopmental Disorders Completed NCT02227381
53 Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities Completed NCT02772432
54 Screening for Glucose Intolerance and Development of a Lifestyle Education Programme for Prevention of Type 2 Diabetes in a Population With Learning Disabilities Completed NCT02513277
55 Assessment of a Drama Workshop Program for Immigrant and Refugee Adolescents Completed NCT01426451
56 The Prenatal Effects of Congenital Heart Disease on Neurodevelopmental Outcome Completed NCT00713635
57 Learning Disabilities: Links to Schools and Biology Completed NCT00061412
58 Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being. "Effets de l'entraînement Physique Intensif Sur la plasticité cérébrale, la Cognition et le Bien être Psychologique". Completed NCT02970825
59 Functional MRI Study of the Involvement of Cortico-cerebellar and Cortico-striatal Networks in Children With a Developmental Coordination Disorder (DCD) and/or Developmental Dyslexia (DD) Completed NCT02393729
60 The Effects of Play and Competition-Based Cognitive Therapy on Executive Functions and Occupational Routines in Children With Dyslexia Completed NCT03906097
61 Effects Of A Computerized Working Memory Training Program On Attention, Working Memory, And Academics, In Adolescents With Severe ADHD/LD Completed NCT00930449
62 Morphofunctional Imaging and Developmental Dyslexia Completed NCT00254644
63 Developmental Dyslexia and Functional Maturation of Auditory Cortex Completed NCT00245804
64 Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter Syndrome Completed NCT00523835
65 Adaptation Among Adolescents and Adults With Klinefelter Syndrome Completed NCT00896272
66 Department of Orthopedic Surgery, Faculty of Medicine Siriraj Hospital Completed NCT01605604
67 Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Completed NCT02843438 Anti-toxoplasmosis treatment;Anti-inflammatory treatments
68 Lifestyle Related Health and Health Promoting Activities for Youths With Intellectual Disabilities Completed NCT01291238
69 Partial Word Knowledge Growth in Children With LLD Completed NCT00547833
70 Neurobiology and Treatment of Reading Disability in Neurofibromatosis Type 1 (NF-1) Completed NCT00624234
71 A Computerised Test for Assessing the Early Reading Skills of Children With Mobility Limitations Completed NCT02797301
72 Cervix Monitor for Risk Assessment of Spontaneous Preterm Delivery Completed NCT03199079
73 Cognitive Effects of Music and Dance Training in Children: A Randomized Controlled Trial Completed NCT03160391
74 Study on the Phenotype of Language in Preterm Born Children at 5 Years of Age Completed NCT02988570
75 Add-on Pilot Trial of Minocycline in Fragile X Syndrome Completed NCT00858689 Minocycline
76 Improving Anxiety Detection in Pediatrics Using Health Information Technology Completed NCT02562248
77 Support Staff's Interactions With Adults With Intellectual Disability Who Use Augmentative and Alternative Communication Completed NCT02099773
78 Nutrition Education Intervention to Promote Dietary Calcium Intake Among Vietnamese Women Aged 30-65 Years in Rural Areas in Hanoi, Vietnam Completed NCT04196426
79 Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (HIE) Control Levels Completed NCT02349672
80 Movement Velocity and Fluidity Improve After Armeo®Spring Rehabilitation in Children Affected by Acquired and Congenital Brain Diseases: an Observational Study Completed NCT03552614
81 SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit Completed NCT01995097
82 Genetic Evaluation for the Scoliosis Gene(s) in Patients With Neurofibromatosis 1 and Scoliosis Completed NCT01776125
83 Longitudinal Assessment of Amyloid Positron Emission Tomography (PET), Fludeoxyglucose F18 (FDG) PET, Tau PET, Magnetic Resonance Imaging (MRI), and Blood Spot Ribonucleic Acid (RNA) in Down Syndrome Individuals With and Without Alzheimer's Dementia and Normal Controls Completed NCT02759887
84 Johnston County ADHD Study: Environmental, Reproductive and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD) Completed NCT00339729
85 The Effectiveness of Neuropsychological Rehabilitation in Young Dyslexic Adults - a Single Blind, Randomized, Controlled Study Completed NCT01930500
86 Cognitive Rehabilitation of Children With Sickle Cell Disease: A Pilot Study Completed NCT01793740
87 Effects of a Web-based Training Programme for Professional Carers Working With People With Learning Disabilities Who Exhibit Challenging Behaviour Completed NCT03390868
88 The Experiences and Needs of Parents Continuing a Pregnancy Following Abnormal Prenatal Results: The Case of Holoprosencephaly Completed NCT00005016
89 Metacognitive Self-regulated Learning and Sensory Integrative Approaches for Children With Autism Spectrum Disorders Completed NCT02496819
90 Evaluation of a Modified Dialectical Behavior Therapy Program for Borderline Personality Disorder Completed NCT01635556
91 Effects of Early Intervention for Preterm Children at School Age Completed NCT01952093
92 Corpus Callosum Agenesis and Intellectual Disability: Genetic and Phenotypic Characterization Completed NCT02167568
93 A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures Completed NCT02115776 Amoxicillin-Potassium Clavulanate;Amoxicillin;Chlorhexidine
94 Reducing Sleep Disparities in Urban, Minority School-Aged Children Completed NCT01301989
95 Computerized Eye-tracking Attention Training for Children With Special Needs Completed NCT04178421
96 Effects of a Task Oriented Intervention for Children With Disabilities, Based on Children's or Parent's Goals, a Randomized Study. Completed NCT02160886
97 The Effectiveness of Videoconferencing on Teaching Parent Training Skills to Parents of Children With ADHD Completed NCT01161719
98 Role of Sleep Apnea in the Neuropsychological Function in Down Syndrome People Completed NCT03267602
99 Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome Completed NCT01367834 somatotropin
100 HIV Prevention Among Alternative School Youth Completed NCT00223314
101 The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes Completed NCT01818778
102 Community-based Perinatal and Newborn Care in Gilgit District, Northern Areas, Pakistan: an AKU-AKHSP Collaboration Completed NCT02412293
103 Developing and Evaluating a Meta-cognitive Intervention Amongst Adolescents With Neuro-development Disabilities Completed NCT03618563
104 Effects of a Combination of Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Non-fluent Aphasia Completed NCT02226796
105 Visual Discomfort and Reading Completed NCT00402155
106 TEOAE Suppression in Children With Auditory Processing Difficulty Completed NCT00001957
107 Computerized Cognitive Rehabilitation in Children After Severe Malaria Completed NCT01743417
108 Cognitive Function in Leukocyte Disorders Completed NCT00005933
109 Computer-Based Cognitive Remediation in Adolescents With VCFS Completed NCT00917189
110 Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients Completed NCT02465424
111 Pilot Study of EEG and Cerebral Blood Flow Biofeedback Training in Remediating Cognitive and Behavioral Deficits in Adults With a Dementing Illness. Completed NCT01168466
112 Effectiveness of Visual Pedagogy-assisted Tooth-brushing Training Among Preschoolers With Special Needs for Oral Health Promotion Completed NCT03522337
113 A Randomized Intervention, Multi-Center Study to Determine the Role of Fatty Acids in Serum in Preventing Retinopathy of Prematurity (MDM) Completed NCT03201588
114 A Randomized Controlled Trial of Brief Culturally Adapted CBT for Schizophrenia in Pakistan Completed NCT01876056
115 High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions Completed NCT01814527 Placebo
116 A Randomised Controlled Trial of Brief Culturally Adapted CBT for Depression in Pakistan Completed NCT01799551
117 A Mixed Methods Study to Design and Test Effectiveness of a Psycho-social Training Intervention on Psychological Health of Parents for Intellectually Disabled Children in Malawi Completed NCT02827396
118 Sensitivity of the Search for a Heterophory-Vertical-Labile (HV-Labile) for Ambulatory Screening for Specific Learning Disabilities (SLD) or Developmental Coordination Disorder (DCD). Recruiting NCT04122820
119 Severe LD in Juvenile Delinquents: Presentation, Course, and Remediation Recruiting NCT03261076
120 Improving STEM Outcomes for Young Children With Language Learning Disabilities by Intervening at the Intersection of Language and Scientific Thought. Recruiting NCT03438760
121 The Effects of Intranasal Oxytocin on Reward Sensitivity and Performance Monitoring During Reinforcement Learning: an ERP Study Recruiting NCT03846271 intranasal oxytocin;intranasal placebo
122 An Alternative Perspective to Comprehend Handwriting Performance: Development and Applications of a Biomechanical Assessment and Biofeedback-training System for Handwriting (BABSH) Recruiting NCT03822702
123 Assessment of the Diagnostic Approach to Specific Language Disorders and Learning Using a New Calibrated Tool: the Modular Battery Tests Computerized (BMTi) Recruiting NCT03919357
124 Patient Education at Dismissal After Surgical Procedure: Clinical Outcome Implications and Improvement Strategies Recruiting NCT03815500
125 Integrating Attention and Self-Regulation Into an Intensive Intervention for Middle School English Learners With Persistent Reading Difficulties Recruiting NCT03695068
126 Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain: Combination of Intracerebral Stereotactic Electroencephalography Recording and Diffusion Tensor Imaging in Children With Drug-resistant Focal Epilepsy Recruiting NCT03268824
127 Resiliency Training in Adolescents With NF1 and NF2; A Randomized Controlled Trial Via Secure Live Video Conferencing to Improve Emotional, Social and Physical Function Recruiting NCT03873610
128 An Evaluation of the Tolerance, Compliance, Acceptability and Safety of a New Oral Nutritional Supplement in Dysphagic Patients Recruiting NCT03679078
129 Does Timing Matter? Efficacy of Parent Provided, Therapist Supported, Motor and Cognitive Intervention for Infants Born Very Preterm in the First Months of Life Recruiting NCT03518736
130 Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD) Recruiting NCT03064048
131 Effects of the Periodic Application of in Situ Simulation in Cardiopulmonary Resuscitation: Randomized Controlled Trial. Recruiting NCT03626272
132 Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy. Recruiting NCT03865771
133 An Evaluation of Early Use of the Tortle Midliner and Intraventricular Hemorrhage (IVH) Outcomes in Premature Babies: A Randomized Controlled Trial Recruiting NCT03543046
134 Babble Boot Camp: Preventing Speech and Language Disorders in Children With Classic Galactosemia Recruiting NCT03838016
135 Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers Recruiting NCT04108728
136 Clinical and Cost Effectiveness of a Parent Mediated Intervention to Reduce Challenging Behaviour in Pre-schoolers With Moderate to Severe Learning Disability: a Randomised Controlled Trial Recruiting NCT03086876
137 Clinical and Basic Investigations Into Smith-Lemli-Opitz Syndrome Recruiting NCT00001721
138 Biomarker for Duchenne Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL Recruiting NCT02994030
139 The Effectiveness of an Educational Program on Parenting Stress and Coping Mechanism Among Parents of Children With Autism Spectrum Disorder in Amman, Jordan Recruiting NCT03805828
140 Craniosynostosis Network Recruiting NCT03025763
141 Complex Motor Learning With Motor Imaginary Recruiting NCT02999516
142 An Evaluation of an ACT and PBS Group for Parents and Education Staff of Children and Young People With an Intellectual Disability Recruiting NCT03917329
143 Clinical and Cost Evaluation of Intensive Support Teams (IST) for Adults With Intellectual Disabilities and Challenging Behaviour Recruiting NCT03586375
144 Neural Damage and Anesthetic Treatment in the Preeclamptic Parturient; a Prospective Observational Cohort Study. Recruiting NCT03551223
145 Perceptual Learning and Memory Consolidation in Adults With and Without Language Impairment Recruiting NCT03609502
146 One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy: A Randomized Controlled Trial Recruiting NCT02936024
147 Enhancing IEPs of Children With ADHD Using Daily Report Cards: An Efficacy Trial Recruiting NCT03747887
148 The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy Recruiting NCT03396562
149 Novel Network Analysis of Intracranial Stereoelectroencephalography Recruiting NCT03916848
150 Influence of a Intervention Break on a Treated Phonological Process in Spontaneous Speech Situations in Children Aged 5 to 6 Years With Phonologically Delayed Development Recruiting NCT03972891
151 Genetic Modifiers of 22q11.2 Deletion Syndrome Active, not recruiting NCT00556530
152 Efficacy of the MovinCog Intervention in Children: A Randomized, Placebo-controlled Trial Active, not recruiting NCT03255499
153 Remédiation Orthophonique couplée à Une Prise en Charge Proprioceptive de la Dyslexie. Etude Comparative randomisée Active, not recruiting NCT03448237
154 Efficacy of the Direct Instruction Language for Learning Program to Promote Expressive and Receptive Language in Children With Autism Spectrum Disorder Active, not recruiting NCT02483910
155 Conditioning Neural Circuits to Improve Upper Extremity Function Active, not recruiting NCT02611375
156 Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction? Active, not recruiting NCT02005185
157 Randomized Controlled Trial of Collaborative & Proactive Solutions (CPS) - an Intervention Model for Young People With Explosive and Challenging Behavior Active, not recruiting NCT03780413
158 Increasing the Reach of Promising Dropout Prevention Programs: Examining the Trade-offs Between Scale and Effectiveness Active, not recruiting NCT02889640
159 Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study Active, not recruiting NCT02622360
160 Improving the Academic Performance of First-Grade Students With Reading and Math Difficulty Enrolling by invitation NCT03991234
161 The Becoming of Children With Doose Syndrome Not yet recruiting NCT04048213
162 Evaluation of the Performance and Safety of a Scintillating Lamp Developed to Improve the Reading of Dyslexic Patients Not yet recruiting NCT04157829
163 Assessment of Intellectual Abilities for Subjects With Velopharyngeal Incompetence and Their Impact on Speech Intelligibility Not yet recruiting NCT03898713
164 Making Mindfulness Matter in Children With Epilepsy Not yet recruiting NCT04020484
165 Prevalence of Tics in Childern With Acute Deficit Hyper Activity Syndrom Not yet recruiting NCT03817710
166 Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children Not yet recruiting NCT03518710
167 Developmental Dyslexia and Remediation Methods. Phonological, Visual-attentional and Cross-modal Approaches, a Multicentric Study. Not yet recruiting NCT04028310
168 Low Intensity Focused Ultrasound of Medial Temporal Lobe Regions for the Improvement of Learning and Memory Not yet recruiting NCT03717922
169 Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics Terminated NCT00078091
170 Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage Terminated NCT00665769
171 Reliability of Clinical Eye Movement Tests as Screening Devices for Reading Disabilities Terminated NCT01860027
172 Identification of Hereditary Auditory Temporal Processing Deficits Terminated NCT00004570
173 Facilitating Numerical Processing With Transcranial DC Stimulation in Developmental Dyscalculia Withdrawn NCT01195961
174 Preschool Literacy Screening: Validating a 5 Question Survey Using the GRTR-R and Evaluation of the Efficacy of Literacy-promoting Interventions. Withdrawn NCT01905332
175 Prospective Analysis of Regional Cerebral Perfusion Using Head Ultrasound and Multi-source-detector Near Infrared Spectroscopy (NIRS) Imaging Withdrawn NCT01082536
176 Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their Parents Withdrawn NCT01182857

Search NIH Clinical Center for Learning Disability

Cochrane evidence based reviews: learning disabilities

Genetic Tests for Learning Disability

Genetic tests related to Learning Disability:

# Genetic test Affiliating Genes
1 Learning Disabilities 29

Anatomical Context for Learning Disability

MalaCards organs/tissues related to Learning Disability:

40
Brain, Testes, Eye, Heart, Thyroid, Cortex, Temporal Lobe

Publications for Learning Disability

Articles related to Learning Disability:

(showing 7680, show less)
# Title Authors PMID Year
1
Reading deficits correlate with cortical and subcortical volume changes in a genetic migration disorder. 42
31490406 2019
2
Alexia and Agraphia from 1861 to 1965. 42
31220840 2019
3
Kanji (Morphogram) and Kana (Phonogram) Problem in Japanese Alexia and Agraphia. 42
31220841 2019
4
Needing permission: The experience of self-care and self-compassion in nursing: A constructivist grounded theory study. 61
31670223 2020
5
Academic Achievements of College Graduates With Learning Disabilities Vis-a-Vis Admission Criteria and Academic Support. 61
31674261 2020
6
Cerebellar function in children with and without dyslexia during single word processing. 61
31597004 2020
7
A novel missense variant in the BBS7 gene underlying Bardet-Biedl syndrome in a consanguineous Pakistani family. 61
31469663 2020
8
Disability advocacy messaging and conceptual links to underlying disability identity development among college students with learning disabilities and attention disorders. 61
31422170 2020
9
The impact of staff training on special educational needs professionals' attitudes toward and understanding of applied behavior analysis. 61
29121825 2019
10
Use of prophylactic antivirals and care home characteristics associated with influenza in care homes with confirmed outbreaks. 61
31533085 2019
11
Examining the Preferred Learning Styles of U.S. Dental Students with Learning Disabilities. 61
31818983 2019
12
Using telemonitoring to support personal care planning for adults with learning disabilities. 61
30016895 2019
13
Excessive Seizure Clusters in an Otherwise Well-Controlled Epilepsy as a Possible Hallmark of Untreated Vitamin B6-Responsive Epilepsy due to a Homozygous PLPBP Missense Variant. 61
31687261 2019
14
L-carnitine supplementation as a potential therapy for suspected hyperammonaemic encephalopathy. 61
31808457 2019
15
Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience. 61
31850678 2019
16
Adult onset seizures in learning disability. 61
31808460 2019
17
Skin fairness is a better predictor for impaired physical and mental health than hair redness. 61
31792316 2019
18
Preschool deficits in cardinal knowledge and executive function contribute to longer-term mathematical learning disability. 61
31430570 2019
19
Attitudes and perceptions of people with a learning disability, family carers and paid care workers, towards cancer screening programmes in the United Kingdom: A qualitative systematic review and meta-aggregation. 61
31834649 2019
20
An evaluation of positive behavioural support implemented within an intensive community support service for people with learning disabilities who present with behaviours that challenge. 61
31835956 2019
21
Resumption of attention-deficit hyperactivity disorder medication in early adulthood: findings from a UK primary care prescribing study. 61
30949828 2019
22
Assessing autism in females: The importance of a sex-specific comparison. 61
31558402 2019
23
The nature and nurture of ADHD and its comorbidities: a narrative review on twin studies. 61
31838192 2019
24
Sleep-related rhythmic movements and rhythmic movement disorder beyond early childhood. 61
31683092 2019
25
Grange syndrome due to homozygous YY1AP1 missense rare variants. 61
31633303 2019
26
Providing more evidence on LZTR1 variants in Noonan syndrome patients. 61
31825158 2019
27
VAC14 syndrome in two siblings with retinitis pigmentosa and neurodegeneration with brain iron accumulation. 61
31387860 2019
28
Prenatal exposure to artificial food colorings alters NMDA receptor subunit concentrations in rat hippocampus. 61
31679476 2019
29
Felicisima C. Serafica (1932-2019). 61
31697137 2019
30
A national survey of school psychologists' practices in identifying specific learning disabilities. 61
31682138 2019
31
"Horrific" treatment of children with learning disabilities must be ended, say MPs and peers. 61
31685490 2019
32
Health-related quality of life and the burden of prolonged seizures in noninstitutionalized children with epilepsy. 61
31733569 2019
33
Magnetic Source Imaging Localization of 14 and 6 Hz Positive Bursts. 61
31466540 2019
34
Specific Learning Disabilities: The Family Physician's Role. 61
31730315 2019
35
The management of patients with learning difficulties and testicular cancer: overcoming barriers to improve care. 61
31727635 2019
36
An Epidemiological Study on the Children with Chinese Developmental Dyslexia. 61
31764410 2019
37
The Florida State Twin Registry. 61
31685063 2019
38
Early attenuation of autonomic nervous function in senescence accelerated mouse-prone 8 (SAMP8). 61
31168043 2019
39
A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience. 61
31192534 2019
40
One size does not fit all: mental health services access for people with intellectual/learning disability requires individualised planning and education/training programmes for health and social care providers. 61
31772063 2019
41
Medical students' perspectives on the article 'delivering a learning disability OSCE station - challenges and solutions'. 61
31580230 2019
42
Managing health changes for people with a learning disability in a residential care home setting. 61
31755831 2019
43
Differences in specific learning disability identification with the Woodcock-Johnson IV. 61
31697146 2019
44
Towards a South African model of language-based learning disability. 61
31793312 2019
45
Delivering a learning disability OSCE station - medical students' perspective. 61
31580215 2019
46
Sleep problems in children who stutter: Evidence from population data. 61
31522013 2019
47
Post-weaning social isolation of mice: A putative animal model of developmental disorders. 61
31708401 2019
48
Impact of mentoring on socio-emotional and mental health outcomes of youth with learning disabilities and attention-deficit hyperactivity disorder. 61
31649490 2019
49
RPE65-Related Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy 61
31725251 2019
50
Treatment of pediatric extra-axial sinogenic infection: case series and literature review. 61
31773238 2019
51
The impact of an adult intellectual disability screening questionnaire on service providers and users. 61
31746057 2019
52
Association between vertigo, cognitive and psychiatric conditions in US children: 2012 National Health Interview Survey. 61
31809971 2019
53
Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1. 61
31730495 2019
54